- What do I need to know about quitting?
- Why should I quit?
- When smokers quit — what are the benefits over time?
- Immediate rewards of quitting
- Social acceptance
- Health of others
- Setting an example
- Help with the mental part of addiction
- Help with the physical part of addiction
- What are the types of nicotine replacement therapy?
- Prescription drugs
- Other methods of quitting
- A word about quitting success rates
- How to quit
- Some special concerns
- To learn more
Abbot NC, Stead LF, White AR, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2000;(2):CD001008.
American Cancer Society. Cancer Facts & Figures 2012. Atlanta, Ga. 2012.
American Cancer Society. Cancer Facts & Figures 2013. Atlanta, Ga. 2013.
American Lung Association. Trends in Tobacco Use. 2011. Accessed at www.lungusa.org/finding-cures/our-research/trend-reports/Tobacco-Trend-Report.pdf September 19, 2012.
American Nonsmokers’ Rights Foundation. U.S. Colleges and Universities with Smokefree and Tobacco-Free Policies. July 1, 2012. Accessed at www.no-smoke.org/pdf/smokefreecollegesuniversities.pdf on September 14, 2012.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision (DSM-IV-TR). 2000, Washington DC: American Psychiatric Association.
Bacher I, Houle S, Xu X, et al. Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Arch Gen Psychiatry. 2011;68(8):817-826.
Barnes J, Dong CY, McRobbie H, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2010;(10):CD001008.
Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116(2):364-374.
Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet. Epub ahead of print September 9, 2013.
Buist AS, McBurnie MA, Vollmer WM , et al, on behalf of the BOLD Collaborative Research Group. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-750.
CDC National Center For Chronic Disease Prevention and Health Promotion. Quit to Live: How and Why to Quit Smoking Today. Accessed at www.cdc.gov/tobacco/news/QuitSmoking.htm on September 12, 2006. Content no longer available.
Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs --- United States, 2000–2004. MMWR. 2008;57:1226-1228. Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm on October 26, 2011.
Centers for Disease Control and Prevention (CDC). Cigarette Smoking Among Adults and Trends in Smoking Cessation --- United States, 2008. MMWR. 2009;58(44):1227-1232. Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/mm5844a2.htm on September 19, 2012.
Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults – United States, 2011. MMWR. 2012;61(44):889-894.
Centers for Disease Control and Prevention (CDC). Quitting Smoking Among Adults --- United States, 2001 -- 2010. MMWR. 2011;60(44);1513-1519. Accessed at www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a2.htm?s_cid= mm6044a2.htm_w on September 19, 2012.
Centers for Disease Control and Prevention (CDC). Smoking Cessation and Interventions Fact Sheet. Accessed at www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm on September 19, 2012.
Clarke LA, Cassidy CW, Catalano G, Catalano MC, Carroll KM. Psychosis induced by smoking cessation clinic administered anticholinergic overload. Ann Clin Psychiatry. 2004;16(3):171-175.
Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction. 2011;106(1):52-61.
Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2012;9:CD010078.
Ebbert JO, Burke MV, Hays JT, Hurt RD. Combination treatment with varenicline and nicotine replacement therapy. Nicotine Tob Res. 2009;1:572-576.
Ebbert JO, Hays JT, Hurt RD. Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs. 2010;70(6):643-650.
Fagerstrom KO, Hughes JR. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine Tob Res. 2002;4 Suppl 2:573-579.
Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. Accessed at www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf on September 19, 2012.
Gaither KH, Brunner Huber LR. Thompson ME, Huet-Hudson YM. Does the Use of Nicotine Replacement Therapy During Pregnancy Affect Pregnancy Outcomes? Matern Child Health J. 2009;13:497-504.
Herraiz T, Chaparro C. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun. 2005;326(2):378-386.
Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005;55:281-299.
Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9:315-327.
Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD000031.
Joad JP. Smoking and pediatric respiratory health. Clin Chest Med. 2000;21:37-46,vii-viii.
Joseph AM, Fu SS. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Prog Cardiovasc Dis. 2003;45:429-441.
Joseph AM, Fu SS. Smoking cessation for patients with cardiovascular disease: What is the best approach? Am J Cardiovasc Drugs. 2003;3:339-349.
Keller PA, Beyer EJ, Baker TB, et al. Tobacco Cessation Quitline Spending in 2005 and 2006: What State-Level Factors Matter? Int. J. Environ. Res. Public Health. 2009;6:259-266.
Oncken C, Gonzales D, Nides M, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med. 2006;166:71-77.
Mahmud, A, Feely, J. Effect of Smoking on Arterial Stiffness and Pulse Pressure Amplication. Hypertension. 2003;441:183.
Manufacturer’s product information. September 2010. Accessed at http://us.gsk.com/products/assets/us_zyban.pdf on September 19, 2012.
Medioni J, Berlin I, Mallet A. Increased risk of relapse after stopping nicotine replacement therapies: A mathematical modeling approach. Addiction. 2005;100:247-254.
Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010;8:8.
Moore D, Aveyard P, Connock M, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.
Nides, M. Oncken C, Gonzales D, et al. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo-and bupropion-controlled trial with 1-year follow-up. Arch Intern Med. 2006;166:1561-1568.
Schroeder SA. What to do with a patient who smokes. Grand Rounds at the University of California, San Francisco. JAMA. 2005;294:482-487.
Shiffman S, Ferguson SG, Gwaltney CJ, et al. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology. 2006;184:637-644.
Shiffman S, Scharf DM, Shadel WG, et al. Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006;74:276-285.
Shiri R, Häkkinen J, Koskimäki J, et al. Smoking causes erectile dysfunction through vascular disease. Urology. 2006;68:1318-1322.
Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146.
Underner M, Paquereau J, Meurice JC. Cigarette smoking and sleep disturbances. Rev Mal Respir. 2006;23 Suppl 3: 67-77.
US Department of Health and Human Services. A Report of the Surgeon General: How Tobacco Smoke Causes Disease…what it means to you. 2010. Accessed at www.cdc.gov/tobacco/data_statistics/sgr/2010/consumer_booklet/pdfs/consumer.pdf on September 17, 2012.
US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. 2006. Accessed at www.surgeongeneral.gov/library/secondhandsmoke/report/ on September 19, 2012.
US Department of Health & Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. 1990. Accessed at http://profiles.nlm.nih.gov/NN/B/B/C/T/ on September 19, 2012.
US Department of Health & Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. 2004. Accessed at www.surgeongeneral.gov/library/smokingconsequences/ on September 19, 2012.
US Department of Health & Human Services. The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General. 1988. Accessed at http://profiles.nlm.nih.gov/NN/B/B/Z/D/on September 19, 2012.
US Department of Health & Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General: 1989 Executive Summary. 1989. Accessed at http://profiles.nlm.nih.gov/NN/B/B/X/S/ on September 19, 2012.
US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. 2000. Accessed at www.cdc.gov/tobacco/data_statistics/sgr/2000/complete_report/index.htm on September 19, 2012.
US Department of Health and Human Services. The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. 1986. Accessed at http://profiles.nlm.nih.gov/NN/B/C/P/M/_/nnbcpm.pdf on September 19, 2012.
US Department of Health and Human Services. US Food and Drug Administration. Summary of Results: Laboratory Analysis of Electronic Cigarettes Conducted By FDA. Accessed at www.fda.gov/NewsEvents/PublicHealthFocus/ucm173146.htm on September 19,2012.
US Food and Drug Administration. Electronic Cigarettes. Updated 10/6/11. Accessed at www.fda.gov/newsevents/publichealthfocus/ucm172906.htm on September 19, 2012.
US Food and Drug Administration. FDA Acts Against 5 Electronic Cigarette Distributors. (Press Release September 10, 2010.) Accessed at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225224.htm on September 19, 2012.
West R, Zatonski W, Cedzynska M, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med. 2011;365(13):1193-1200.
White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2006;(1):CD000009.
Last Medical Review: 10/04/2012
Last Revised: 09/09/2013